“Combination effect of doxorubicin and HIF inhibitor on MCF-7 CD44+/CD24- subpopulation cells in hypoxic condition”, Braz. J. Pharm. Sci., vol. 58, Dec. 2022, doi: 10.1590/s2175-97902020000318754 .